Clinical study of Sublingal immunotherapy with Lactobacillus strain for patients with Japanese cedar pollinosis : A Randomized Placebo-Controlled Trial
Phase 3
- Conditions
- Japanese cedar pollen allergy
- Registration Number
- JPRN-UMIN000001449
- Lead Sponsor
- Department of Otorhinolaryngology in Ciba University Graduate School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)The history of severe asthma 2)The history of anti-allergic drugs within 4 weeks 3)Perior history of immunotherapy with cedar pollen 4)Pregnant women and those at risk of pregnancy 5)Complication of the other nasal-paranasal disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ISymptom-medication score
- Secondary Outcome Measures
Name Time Method ocal findings in rhinoscope Serum anti-Japanese cedar pollen specific IgE antibody Serum ECP level Lymphocyte Subsets of Peripheral Blood Mononuclear Cell (Immunophenotyping)